AnalystsCatherine NovackCatherine Novack's Stock Forecasts
AnalystsCatherine Novack
Analyst Ranking
Bottom 12%
#4078 out of 4586 analysts
Average Return
-20.58%
Win Rate
22%2 out of 9
Risk vs Reward
Poor
Good
Catherine Novack Analyst Color
Get additional color on Catherine Novack's coverage of popular stocks
Catherine Novack's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rezolute IncRZLT | 1 | Strong Buy | $10.00 | +277.36% | Initiates Coverage On | a month ago |
Femasys IncFEMY | 1 | Strong Buy | $10.00 | +651.88% | Maintains | 2 months ago |
Calcimedica IncCALC | 1 | Strong Buy | $22.00 | +301.46% | Initiates Coverage On | 3 months ago |
Purple Biotech LtdPPBT | 1 | Strong Buy | $8.00 | +1,500.00% | Initiates Coverage On | 10 months ago |
Omega Therapeutics IncOMGA | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | a year ago |
Dare Bioscience IncDARE | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | a year ago |
Decibel Therapeutics IncDBTX | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Amryt Pharma PLCAMYT | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |
Kezar Life Sciences IncKZR | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.